Efficacy, safety and the lymphocyte subsets changes of low‐dose IL‐2 in patients with systemic lupus...
Efficacy, safety and the lymphocyte subsets changes of low‐dose IL‐2 in patients with systemic lupus erythematosus: A systematic review and meta‐analysis
About this item
Full title
Author / Creator
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Introduction
Existing therapies of systemic lupus erythematosus (SLE) are efficacious only in certain patients. Developing new treatment methods is urgent. This meta‐analysis aimed to evaluate the efficacy and safety of low‐dose IL‐2 (LD‐IL‐2).
Methods
According to published data from PubMed, Web of Science, Embase, ClinicalTrials.gov, MED...
Alternative Titles
Full title
Efficacy, safety and the lymphocyte subsets changes of low‐dose IL‐2 in patients with systemic lupus erythematosus: A systematic review and meta‐analysis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_472a7f51f1114a5c8739112fbfcfdc61
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_472a7f51f1114a5c8739112fbfcfdc61
Other Identifiers
ISSN
2050-4527
E-ISSN
2050-4527
DOI
10.1002/iid3.1165
